Global corporate merger and acquisition (M&A) activity fell in 2012 from the previous year and was the lowest for deal values since 2010, a survey by Mergermarket shows.
The value of deals, at $US2174.5 billion, was down 2.7% on 2011 but rose 13.3% in the second half. The fourth quarter’s $US672.9 billion-worth of deals was the highest quarter since the corresponding period in 2010 and was up 45.6% on the same period in 2011.
The largest M&A transaction was the $US45.6 billion all-equity takeover of Xstrata by Switzerland-based Glencore International, followed by Japan-based Softbank’s all-cash offer for the US-based Sprint Nextel valued at $US35.5 billion.
Mega-deals in Asia-Pacific (excluding Japan) were up for a second year to 13% of overall M&A value in the region, the highest level since 2008.
Global bidders looking for Asia-Pacific targets favoured Chinese targets, with 627 deals valued at $US126.7 billion, followed by those in Japan (368 deals worth $US72.5 billion) and Australia (397 deals worth $US46.1 billion). A drop-off in energy and mining deals took its toll on Australian totals.
The bidding war for Singapore conglomerateFraser & Neave was the centre of attention in the region in 2012, with companies from Thailand, Indonesia, Singapore and Japan fighting over control.
As a result, Dutch brewer Heineken ended up with F&N’s shareholding in Asia Pacific Breweries, parent company of New Zealand’s DB Breweries.
Private equity buyouts in Asia-Pacific (excl Japan) slid 30.7% on 2011 to $US27.2 billion, the worst year for buyouts in the region since 2009.
Goldman Sachs maintained its place at the top of adviser league tables both globally and in Asia-Pacific,
with Citi and Credit Suisse second and third respectively in Asia Pacific.
This article is tagged with the following keywords. Find out more about MyNBR Tags
Most listened to
- Who are the winners and losers in Labour's re-shuffle? Rob Hosking explains
- Head-to-head: Federated Farmers director Katie Milne and SAFE executive director Hans kriek debate dairy industry's treatment of bobby calves
- Full Flavour managing director Jesse Archer says Ultra Fast Fibre gave him the "two fingered salute"
- Rob Hosking gives his in-depth analysis on the big stories to watch out for this week
- Nevil Gibson discusses his latest Editor's Insight on regional development
- AFT Pharmaceuticals founder Dr Hartley Atkinson talks about why he's going public